Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.66 USD | -1.59% | +5.22% | +136.61% |
05-29 | Baird Starts Mind Medicine (MindMed) With Outperform Rating, $27 Price Target | MT |
05-13 | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+136.61% | 622M | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+37.66% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- MNMD Stock
- News Mind Medicine (MindMed) Inc.
- Transcript : Mind Medicine Inc., Q1 2023 Earnings Call, May 04, 2023